Clinical Trials Logo
  1. Home
  2. Congenital Heart Disease
  3. NCT04807621
  4. Details
NCT04807621 Clinical Trial

Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery

Congenital Heart Disease Clinical Trial

Official title:
Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery: a Randomized, Controlled Trial.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04807621
Other study ID # FS52016
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date March 14, 2018
Est. completion date August 2022

Study information
Verified date March 2021
Source Sahlgrenska University Hospital, Sweden
Contact Fredrik Söderlund, MD
Phone +46 31 343 6895
Email fredrik.soderlund@vgregion.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to test whether platelet transfusion or fibrinogen concentrate is the most effective treatment of intraoperative bleeding, when performing open heart surgery with cardiopulmonary bypass on children with congenital heart defects.

Recruitment information / eligibility
Status Recruiting
Enrollment 40
Est. completion date August 2022
Est. primary completion date January 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Months
Eligibility Inclusion Criteria: - Children < 1 years of age, scheduled for open surgery of congenital heart defects, using cardiopulmonary bypass. - Body weight < 10 kg. - Expected CPB time > 90 minutes. Exclusion Criteria: - Known coagulation disorder, current treatment with antiplatelet and/or anticoagulant drugs, major surgery the past month before the planned surgery, preoperative kidney or liver failure (defined as creatinine and/or transaminases > normal interval for the patient´s age), gestational age < 34 weeks.

Study Design

Related Conditions & MeSH terms

Intervention

Biological:
• Platelet transfusion
Platelets (10 ml/kg body weight) is transfused.
• Fibrinogen concentrate
Fibrinogen concentrate (300 mg/kg body weight) is administered.

Locations
Country Name City State
Sweden Sahlgrenska University Hospital Gothenburg

Sponsors (1)
Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary HEPTEM-A10 The outcome measure is a measure of global coagulation efficacy, obtained by ROTEM analysis. 45 minutes after intervention
Secondary Amount of transfused packed red blood cells up to first postoperative morning
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04992793 - Paediatric Brain Injury Following Cardiac Interventions
Recruiting NCT05213598 - Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Completed NCT04136379 - Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
Completed NCT04814888 - 3D Airway Model for Pediatric Patients
Recruiting NCT04920643 - High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery N/A
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Recruiting NCT06041685 - Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia N/A
Recruiting NCT05902013 - Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation N/A
Not yet recruiting NCT05687292 - Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
Not yet recruiting NCT05524324 - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT N/A
Completed NCT02746029 - Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
Completed NCT03119090 - Fontan Imaging Biomarkers (FIB) Study
Completed NCT02537392 - Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease N/A
Recruiting NCT02258724 - Swiss National Registry of Grown up Congenital Heart Disease Patients
Completed NCT01966237 - Milrinone Pharmacokinetics and Acute Kidney Injury
Terminated NCT02046135 - Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery Phase 2
Recruiting NCT01184404 - Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery N/A
Completed NCT01548950 - Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension N/A
Completed NCT01821287 - Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease N/A